People affected by Crohn's disease or ulcerative colitis experience a high level of suffering. A new generation of anti-tumour necrosis factor-α agents can alleviate the burden of symptoms considerably. In order to develop a need-centred care programme ...
Colitis-associated colorectal carcinoma (CRC) accounts for about 5% of all CRC and the risk for CRC in inflammatory bowel disease (IBD) patients – according to older meta-analyses – is slightly increased when compared to normal population. Effective anti-...
During their disease course, the majority of Crohn's disease patients will develop a complicated disease which is characterized by the occurrence of fistulas and/or stenosis. Symptomatic, perianal fistulas should be surgically drained before anti-...
From Axial Spondyloarthritis to Osteoporosis – Spectrum of Skeletal Involvement in Inflammatory Bowel DiseasesAbstract. Inflammatory bowel diseases (IBD) are frequently accompanied by non-inflammatory joint pain ...